News Daily News Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy L.A. McKeown June 01, 2022
News Conference News SCAI 2022 DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year L.A. McKeown May 23, 2022
News Daily News Percutaneous Axillary Access: SCAI Calls for Best Practices Caitlin E. Cox April 20, 2022
News Conference News ACC 2022 Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD L.A. McKeown April 04, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2022 Caitlin E. Cox April 01, 2022